These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 21387773

  • 1. [Withdrawal of maintenance dialysis in a patient with diagnosed multiple myeloma and renal failure as a consequence of effective anti-tumor treatment].
    Rosa J, Sydor A, Jurczyszyn A, Zabawa-Hołyś S, Nowak J, Czapkowicz-Gryszkiewicz L, Sułowicz W.
    Przegl Lek; 2010; 67(7):547-50. PubMed ID: 21387773
    [Abstract] [Full Text] [Related]

  • 2. Multiple myeloma--presenting as acute kidney injury.
    Prakash J, Niwas SS, Parekh A, Vohra R, Wani IA, Sharma N, Usha.
    J Assoc Physicians India; 2009 Jan; 57():23-6. PubMed ID: 19753754
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M, Kondo F, Yamamoto K, Murakami K, Tomita M, Nabeshima K, Nakai S, Kato M, Ohashi A, Arai J, Hiki Y, Ishii J, Emi N, Sugiyama S, Yuzawa Y.
    Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
    [Abstract] [Full Text] [Related]

  • 4. Thalidomide alone or in combination with dexamethasone in patients with advanced, relapsed or refractory multiple myeloma and renal failure.
    Tosi P, Zamagni E, Cellini C, Cangini D, Tacchetti P, Tura S, Baccarani M, Cavo M.
    Eur J Haematol; 2004 Aug; 73(2):98-103. PubMed ID: 15245508
    [Abstract] [Full Text] [Related]

  • 5. [Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].
    de Alarcón Jiménez RM, Roca Meroño S, Alvarez Fernández GM, García Hernández MA, Navarro Parreño MJ, Jimeno Griñó C, Zarco Pedrinaci E, Molina Núñez M.
    Nefrologia; 2011 Aug; 31(2):238-40. PubMed ID: 21461027
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function.
    Nozza A, Siracusano L, Armando S.
    Clin Ther; 2006 Jun; 28(6):953-9. PubMed ID: 16860177
    [Abstract] [Full Text] [Related]

  • 10. Factors associated with recovery of renal function in patients with multiple myeloma who were treated with hemodialysis.
    Katagiri D, Hagiwara S, Minami E, Katsuma A, Masumoto S, Hoshino T, Inoue T, Shibata M, Tada M, Nakamura T, Shimbo T, Hinoshita F.
    Nephron Clin Pract; 2011 Jun; 117(1):c28-32. PubMed ID: 20689322
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of free light chain hemodialysis in myeloma cast nephropathy: a case-control study.
    Peters NO, Laurain E, Cridlig J, Hulin C, Cao-Huu T, Frimat L.
    Hemodial Int; 2011 Oct; 15(4):538-45. PubMed ID: 22111823
    [Abstract] [Full Text] [Related]

  • 13. Optimizing treatment strategies in myeloma cast nephropathy: rationale for a randomized prospective trial.
    Bridoux F, Fermand JP.
    Adv Chronic Kidney Dis; 2012 Sep; 19(5):333-41. PubMed ID: 22920644
    [Abstract] [Full Text] [Related]

  • 14. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
    Borrego-Hinojosa J, Pérez-del Barrio MP, Biechy-Baldan Mdel M, Merino-García E, Sánchez-Perales MC, García-Cortés MJ, Ocaña-Pérez E, Gutiérrez-Rivas P, Liébana-Cañada A.
    Nefrologia; 2013 Sep; 33(4):515-23. PubMed ID: 23897183
    [Abstract] [Full Text] [Related]

  • 15. [IgA pemphigus accompanying multiple myeloma has disappeared following the treatment with bortezomib (Velcade), cyclophosphamide and dexamethasone. Case study and literature review].
    Adam Z, Feit J, Krejcí M, Pour L, Vasků V, Cermáková Z, Mayer J, Hájek R.
    Vnitr Lek; 2009 Oct; 55(10):981-90. PubMed ID: 19947244
    [Abstract] [Full Text] [Related]

  • 16. Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.
    Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D.
    Nephrol Dial Transplant; 2012 Oct; 27(10):3823-8. PubMed ID: 22273664
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: a retrospective study of Italian Myeloma Network GIMEMA.
    Morabito F, Gentile M, Ciolli S, Petrucci MT, Galimberti S, Mele G, Casulli AF, Mannina D, Piro E, Pinotti G, Palmieri S, Catalano L, Callea V, Offidani M, Musto P, Bringhen S, Baldini L, Tosi P, Di Raimondo F, Boccadoro M, Palumbo A, Cavo M.
    Eur J Haematol; 2010 Mar; 84(3):223-8. PubMed ID: 19930441
    [Abstract] [Full Text] [Related]

  • 18. Combination therapy with thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma not undergoing upfront autologous stem cell transplantation: a phase II trial.
    Dingli D, Rajkumar SV, Nowakowski GS, Gertz MA, Dispenzieri A, Lacy MQ, Hayman S, Fonseca R, Lust JA, Kyle RA, Greipp PR, Witzig TE.
    Haematologica; 2005 Dec; 90(12):1650-4. PubMed ID: 16330438
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.